Maipl Therapeutics develops small molecule new drugs to treat endometriosis-related pain, idiopathic pulmonary fibrosis (IPF), and other conditions.  The company’s platform is based on breakthrough FP antagonist (FPA) lead compounds licensed from Ferring Pharmaceuticals.  The FPA leads are potent and highly selective inhibitors of prostaglandin F2α signaling, with therapeutics potentials for menstrual pain, fibrosis, and inflammatory conditions in which elevated F2α causes a detrimental effect.  FPAs have virtually no impact on other essential prostaglandin functions, unlike NSAIDs and COX-2 that are associated with rare but serious GI, renal, and CV side effects.  Maipl has the first-mover advantage in their focused therapeutic areas, and will continue to explore new indications.

RNAConnect was founded by innovators in the RNA community, for innovators in the RNA community. We provide superior enzymatic tools for visualizing and manipulating RNA, to enable the RNA community discover, create, and innovate in ways previously not possible.

Our lead product is UltraMarathonRT ™, a next generation, group II intron-encoded reverse transcriptase. As biotechnology and molecular medicine advance, more powerful tools are needed to accurately monitor and manipulate the complex RNA landscape of living systems. UltraMarathonRT unlocks this potential by reporting on the full transcriptomic complexity of RNA in cells and tissues under a broad set of real-world reaction conditions. Given its unmatched processivity, unwinding efficiency, low abundance RNA sensitivity, and low operating temperature, UltraMarathonRT is an essential component of the genomics toolkit.

KPS Life is a stand-alone, global functional service provider (“FSP”) that offers a clinical outsourcing solution to the Biopharmaceutical and Medical Device & Diagnostic sectors across all phases of clinical drug development. Their services include clinical monitoring, clinical monitoring oversight, clinical trial management, data management, biometrics, and medical writing. The KPS Life FSP model is a proven alternative to traditional staffing and full-service organization methodologies and affords sponsors the opportunity to contract dedicated, embedded resources to complement their clinical teams while maintaining brand identity and strategic control of assets.

Operating in six continents across the globe, KPS Life is committed to working together with its clients through a hands-on operating model rooted in a partnership approach. KPS Life has carved out a leadership position within the FSP market sector by providing customized and scalable solutions that improve the quality and execution of clinical trials while mitigating costs and increasing transparency for its clients.

Founded in 2006, KPS Life is institutionally backed by LongueVue Capital (“LVC”). LVC is an entrepreneur-centric New Orleans based private equity firm focused on partnering with management teams through both growth and controlled investments across a variety of sectors, healthcare being the largest.

Research Activities:

KPS Life currently partners with more than 30 Biopharmaceutical Sponsors in executing their clinical trials across multiple therapeutic areas (most notably Oncology, Rare Disease, Cardio, CNS, Dermatology, Immunology) within all phases of clinical research.

Waters Corporation is the world’s leading specialty measurement company focused on improving human health and well-being through the application of high-value analytical technologies and industry leading scientific expertise.  Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 60 years. With more than 8,200 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.  Specialties include UPLC, HPLC, Chromatography, Mass Spectrometry, Informatics, Thermal Imaging, Chemistry, Analytical Standards & Reagents, Data Integrity, and Specialty Measurement.

Research Activities:

At Waters we are accelerating the benefits of pioneering science for a healthier, safer, and more sustainable world.  Accelerating refers to the drive and passion Waters has to solve the problems that matter at scale so that more people can benefit sooner.  Benefits refer both to those which are directly created by Waters’ products and innovations, to the benefit of Waters’ customers’ products and innovations on human health and well-being.  Pioneering science is all about blazing new trails and doing things previously thought to be impossible. It inspires and brings new hope to people.

ReST Therapeutics is an early-stage, biotech company originally founded in 2020 in Paris, France, now located in New Haven, CT.  ReST is developing transformative therapies for patients with significant, unmet needs in Psychiatry and Neurodegeneration.

With our lead program, RST-01, we intend to disrupt the existing PTSD treatment paradigm by focusing on early intervention, immediately following a traumatic event and a patient-centric clinical development strategy. RST-01 is unique in that it selectively targets the NMDA receptors in the brain which are critical to memory consolidation. Pre-clinical testing has shown drastic reductions in fear, anxiety and depression with RST-01.

Beyond psychiatry, NMDAR selective modulation has demonstrated outstanding results in Alzheimer models, the cognitive function being integrally restored and amyloid put under control through glial cells activity, opening the door to the development of a suite of assets to restore the quality of lives of those affected by debilitating neurodegenerative diseases, particularly ALS and AD.

Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes.

Alert Scientific, an ISO/IEC 17025:2017 Accredited Company, is the laboratory equipment service Preferred Partner for BioCT, MassBio / New England Edge and therefore you are entitled to significant discounts for service.

We provide factory authorized repair services, preventive maintenance and calibration / certification services, and IQ/OQ/PQ validation (including temperature mapping and profiling) for a wide variety of laboratory equipment. We also provide biosafety cabinet decontamination, ASHRAE 110 chemical fume hood testing, inside delivery, installation and set up of lab equipment, as well as ultra low temperature freezer rentals.

Growth. Value. Managing risk. Regardless of how you define it, success in today’s global market means addressing increasingly complex issues faster and more efficiently amid rapid change. Making the right decisions in this environment requires strategic legal counsel from advisors who not only know how laws are evolving but have a deep understanding of how to align legal strategy with commercial objectives. This is Nutter.

Nutter’s life science team, which includes multiple PhDs in various disciplines, knows how critical it is to understand a client’s business and the unique pressures driving it. Our experience runs deep—whether small or large molecules or diagnostics—our life science lawyers tackle matters concerning complex patent prosecution and freedom to operate, licensing and agreements; research and development funding; clinical trial strategy; and FDA safe harbor advice. Clients turn to us for legal counsel throughout all stages of their lifecycle, whether it is the opportunity to collaborate or partner with industry leaders, pursue mission-critical patent protection, or prepare for an initial public offering or a merger/acquisition. By applying our wealth of expertise in biology, chemistry, and related life science technologies, we help transform our clients’ ideas and goals into business strategies and products.

Renovo Life Sciences is passionate about creating Asset and Laboratory Management Solutions that are driven by innovation, transparency, sustainability, and a focus on unbiased results. We provide a single – source Lab Asset Management Solution providing Inventory Management, Asset Utilization, PM scheduling, Calibration and Laboratory Relocation Services.

Renovo’s systematic tracking, organization, and maintenance of your lab equipment, instruments, and resources ensures that our clients can expect improved operational efficiencies that lead to greater asset uptime while reducing inventory costs This, in turn, gives time back to the scientists to focus on science – a win-win solution!

Our mission is enabling our partners with solutions that ensure the quality and speed of science.

Ancora invests in real estate at the heart of innovation. A partnership of Ancora Real Estate Holdings LLC., and Legal & General Capital, Ancora is a vertically integrated investor, developer, and operator of life sciences, research, and mixed-use real estate. Our work sits at the intersection of commercial real estate and the educational, healthcare, R&D and commercialization demands that drive higher education and medical institutions. These anchor institutions must manage disruption, recalibration, and innovation as powerful shifts – demographic, economic, and digital – shape faculty recruitment and student enrollment, finance, research funding, and relationships with neighboring communities and governments. We understand these ongoing dynamics, and craft real estate approaches that echo and enhance each institution’s place and direction. For leaders who recognize and act, these changes present opportunities that can bring broad benefits.